[1]
|
Rhee, C., Dantes, R., Epstein, L., et al. (2017) Incidence and Trends of Sepsis in US Hospitals Using Clinical vs. Claims Data, 2009-2014. Journal of the American Medical Association, 318, 1241-1249. https://doi.org/10.1001/jama.2017.13836
|
[2]
|
Iwashyna, T.J., Ely, E.W., Smith, D.M. and Langa, K.M. (2010) Long-Term Cognitive Impairment and Functional Disability among Survivors of Severe Sepsis. Journal of the American Medical Association, 304, 1787-1794. https://doi.org/10.1001/jama.2010.1553
|
[3]
|
Shapiro, N.I., et al. (2005) Serum Lactate as a Predictor of Mortality in Emergency Department Patients with Infection. Annals of Emergency Medicine, 45, 524-528. https://doi.org/10.1016/j.annemergmed.2004.12.006
|
[4]
|
Martin, G.S., Mannino, D.M., Eaton, S. and Moss, M. (2003) The Epidemiology of Sepsis in the United States from 1979 through 2000. The New England Journal of Medicine, 348, 1546-1554. https://doi.org/10.1056/NEJMoa022139
|
[5]
|
Wang, C., Xu, R., Zeng, Y., Zhao, Y. and Hu, X. (2022) A Comparison of qSOFA, SIRS and NEWS in Predicting the Accuracy of Mortality in Patients with Suspected Sepsis: A Meta-Analysis. PLOS ONE, 17, e0266755. https://doi.org/10.1371/journal.pone.0266755
|
[6]
|
Torio, C.M. and Moore, B.J. (2016) National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013. https://www.hcup-us
|
[7]
|
Paoli, C.J., et al. (2018) Epidemiology and Costs of Sepsis in the United States-An Analysis Based on Timing of Diagnosis and Severity Level. Critical Care Medicine, 46, 889-1897. https://doi.org/10.1097/CCM.0000000000003342
|
[8]
|
Rudd, K.E., Johnson, S.C., Agesa, K.M., Shackelford, K.A., Tsoi, D., Kievlan, D.R., et al. (2020) Global, Regional, and National Sepsis Incidence and Mortality, 1990-2017: Analysis for the Global Burden of Disease Study. The Lancet, 395, 200-211. https://doi.org/10.1016/S0140-6736(19)32989-7
|
[9]
|
Marshall, J.C. (2014) Why Have Clinical Trials in Sepsis Failed? Trends in Molecular Medicine, 20, 195-203. https://doi.org/10.1016/j.molmed.2014.01.007
|
[10]
|
Ventola, C.L. (2015) The Antibiotic Resistance Crisis: Part 1: Causes and Threats. Pharmacy and Therapeutics, 40, 277-283.
|
[11]
|
Coopersmith, C.M. and Deutschman, C.S. (2017) The New Sepsis Definitions: Implications for the Basic and Translational Research Communities. Shock, 47, 264-268. https://doi.org/10.1097/SHK.0000000000000763
|
[12]
|
Deutschman, C.S. and Tracey, K.J. (2014) Sepsis: Current Dogma and New Perspectives. Immunity, 40, 463-475. https://doi.org/10.1016/j.immuni.2014.04.001
|
[13]
|
Hotchkiss, R.S., Coopersmith, C.M., McDunn, J.E. and Ferguson, T.A. (2009) The Sepsis Seesaw: Tilting toward Immunosuppression. Nature Medicine, 15, 496-497. https://doi.org/10.1038/nm0509-496
|
[14]
|
Cauvi, D.M., Song, D., Vazquez, D.E., Hawisher, D., Bermudez, J.A., Williams, M.R., Bickler, S., Coimbra, R. and De Maio, A. (2012) Period of Irreversible Therapeutic Intervention during Sepsis Correlates with Phase of Innate Immune Dysfunction. Journal of Biological Chemistry, 287, 19804-19815. https://doi.org/10.1074/jbc.M112.359562
|
[15]
|
Singer, M., Deutschman, C.S., Seymour, C.W., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Journal of the American Medical Association, 315, 801-810. https://doi.org/10.1001/jama.2016.0287
|
[16]
|
Fleischmann, C., Scherag, A., Adhikari, N.K., Hartog, C.S., Tsaganos, T., Schlattmann, P., et al. (2016) Assessment of Global Incidence and Mortality of Hospital-Treated Sepsis. Current Estimates and Limitations. American Journal of Respiratory and Critical Care Medicine, 193, 259-272. https://doi.org/10.1164/rccm.201504-0781OC
|
[17]
|
Reinhart, K., Daniels, R., Kissoon, N., Machado, F.R., Schachter, R.D. and Finfer, S. (2017) Recognizing Sepsis as a Global Health Priority—A WHO Resolution. The New England Journal of Medicine, 377, 414-417. https://doi.org/10.1056/NEJMp1707170
|
[18]
|
Anand, V., Zhang, Z., Kadri, S.S., Klompas, M., Rhee, C. and CDC Prevention Epicenters Program (2019) Epidemiology of Quick Sequential Organ Failure Assessment Criteria in Undifferentiated Patients and Association with Suspected Infection and Sepsis. Chest, 156, 289-297. https://doi.org/10.1016/j.chest.2019.03.032
|
[19]
|
Rangel-Frausto, M.S., Pittet, D., Costigan, M., Hwang, T., Davis, C.S. and Wenzel, R.P. (1995) The Natural History of the Systemic Inflammatory Response Syndrome (SIRS): A Prospective Study. Journal of the American Medical Association, 273, 117-123. https://doi.org/10.1001/jama.1995.03520260039030
|
[20]
|
Huang, M., Cai, S.L. and Su, J.Q. (2019) The Pathogenesis of Sepsis and Potential Therapeutic Targets. International Journal of Molecular Sciences, 20, Article 5376. https://doi.org/10.3390/ijms20215376
|
[21]
|
Torabi, M., Moeinaddini, S., Mirafzal, A., Rastegari, A. and Sadeghkhani, N. (2016) Shock Index, Modified Shock Index, and Age Shock Index for Prediction of Mortality in Emergency Severity Index Level 3. The American Journal of Emergency Medicine, 34, 2079-2083. https://doi.org/10.1016/j.ajem.2016.07.017
|
[22]
|
Wira, C., Francis, M., Bhat, S., Ehrman, R., Conner, D. and Siegel, M. (2014) The Shock Index as a Predictor of Vasopressor Uses in Emergency Department Patients with Severe Sepsis. Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health, 15, 60-66. https://doi.org/10.5811/westjem.2013.7.18472
|
[23]
|
Koch, E., Lovett, S., Nghiem, T., Riggs, R.A. and Rech, M.A. (2019) Shock Index in the Emergency Department: Utility and Limitations. Open Access Emergency Medicine, 11, 179-199. https://doi.org/10.2147/OAEM.S178358
|
[24]
|
Kabrhel, C., Camargo, C.A. and Goldhaber, S.Z. (2008) Clinical Gestalt and the Diagnosis of Pulmonary Embolism: Does Experience Matter? Chest, 127, 1627-1630. https://doi.org/10.1378/chest.127.5.1627
|
[25]
|
Cook, C. (2009) Is Clinical Gestalt Good Enough? Journal of Manual & Manipulative Therapy, 17, 6-7. https://doi.org/10.1179/106698109790818223
|
[26]
|
Gao, H.M., Ambroggio, L., Shah, S.S., Ruddy, R.M. and Florin, T.A. (2021) Predictive Value of Clinician “Gestalt” in Pediatric Community-Acquired Pneumonia. Pediatrics, 147, e2020041582. https://doi.org/10.1542/peds.2020-041582
|
[27]
|
Li, Y.L., et al. (2018) Gestalt for Shock and Mortality in the Emergency Department: A Prospective Study. The American Journal of Emergency Medicine, 36, 988-992. https://doi.org/10.1016/j.ajem.2017.11.007
|
[28]
|
Pyo, J.Y., Ha, Y.J., Park, Y.B., Lee, S.K. and Lee, S.W. (2017) Delta Neutrophil Index Contributes to the Differential Diagnosis between Acute Gout Attack and Cellulitus within 24 Hours after Hospitalization. Rheumatology, 56, 795-801. https://doi.org/10.1093/rheumatology/kew471
|
[29]
|
Sheikh Motahar Vahedi, H., Bagheri, A., Jahanshir, A., Seyedhosseini, J. and Vahidi, E. (2019) Association of Lymphopenia with Short Term Outcomes of Sepsis Patients; a Brief Report. Archives of Academic Emergency Medicine, 7, e14.
|
[30]
|
Cox, L.E., Walstein, K., Vollger, L., Reuner, F., Bick, A., Dotsch, A., et al. (2020) Neutrophil Extracellular Trap Formation and Nuclease Activity in Septic Patients. BMC Anesthesiology, 20, Article No. 15. https://doi.org/10.1186/s12871-019-0911-7
|
[31]
|
Camicia, G., Pozner, R. and de Larrañaga, G. (2014) Neutrophil Extracellular Traps in Sepsis. Shock, 42, 286-294. https://doi.org/10.1097/SHK.0000000000000221
|
[32]
|
Agnello, L., Vincenza Giglio, R., Bivona, G., et al. (2021) The Value of a Complete Blood Count (CBC) for Sepsis Diagnosis and Prognosis. Diagnostics, 11, Article 1881. https://doi.org/10.3390/diagnostics11101881
|
[33]
|
Lavoignet, C.E., Le Borgne, P., Chabrier, S., Bidoire, J., Slimani, H., Chevrolet-Lavoignet, J., Lefebvre, F., Jebri, R., Sengler, L. and Bilbault, P. (2019) White Blood Cell Count and Eosinopenia as Valuable Tools for the Diagnosis of Bacterial Infections in the ED. European Journal of Clinical Microbiology & Infectious Diseases, 38, 1523-1532. https://doi.org/10.1007/s10096-019-03583-2
|
[34]
|
Lin, Y., Rong, J. and Zhang, Z. (2021) Silent Existence of Eosinopenia in Sepsis: A Systematic Review and Meta-Analysis. BMC Infectious Diseases, 21, Article No. 471. https://doi.org/10.1186/s12879-021-06150-3
|
[35]
|
Vardon-Bounes, F., Ruiz, S., Gratacap, M.P., Garcia, D., Payrastre, B. and Minville, V. (2019) Platelets Are Critical Key Players in Sepsis. International Journal of Molecular Sciences, 20, Article 3494. https://doi.org/10.3390/ijms20143494
|
[36]
|
Hoeboer, S.H., van der Geest, P.J., Nieboer, D. and Groeneveld, A.B.J. (2015) The Diagnostic Accuracy of Procalcitonin for Bacteremia: A Systematic Review and Meta-Analysis. Clinical Microbiology and Infection, 21, 474-481. https://doi.org/10.1016/j.cmi.2014.12.026
|
[37]
|
Rinde, F.B., Fronas, S.G., Ghanima, W., Vik, A., Hansen, J.B. and Brækkan, S.K. (2020) D-Dimer as a Stand-Alone Test to Rule Out Deep Vein Thrombosis. Thrombosis Research, 191, 134-139. https://doi.org/10.1016/j.thromres.2020.04.026
|
[38]
|
Yan, S.T., Sun, L.C., Jia, H.B., Gao, W., Yang, J.P. and Zhang, G.Q. (2017) Procalcitonin Levels in Bloodstream Infections Caused by Various Sources and Species of Bacteria. The American Journal of Emergency Medicine, 35, 579-583. https://doi.org/10.1016/j.ajem.2016.12.017
|
[39]
|
Fan, S.L., Miller, N.S., Lee, J. and Remick, D.G. (2016) Diagnosing Sepsis—The Role of Laboratory Medicine. Clinica Chimica Acta, 460, 203-210. https://doi.org/10.1016/j.cca.2016.07.002
|
[40]
|
Hayashi, Y., Endoh, H., Kamimura, N., Tamakawa, T. and Nitta, M. (2020) Lactate Indices as Predictors of in-Hospital Mortality or 90-Day Survival after Admission to an Intensive Care Unit in Unselected Critically Ill Patients. PLOS ONE, 15, e0229135. https://doi.org/10.1371/journal.pone.0229135
|
[41]
|
Andersen, L.W., et al. (2013) Etiology and Therapeutic Approach to Elevated Lactate. Mayo Clinic Proceedings, 88, 1127-1140. https://doi.org/10.1016/j.mayocp.2013.06.012
|
[42]
|
Sauer, C.M., Gómez, J., Botella, M.R., et al. (2021) Understanding Critically Ill Sepsis Patients with Normal Serum Lactate Levels: Results from U.S. and European ICU Cohorts. Scientific Reports, 11, Article No. 20076. https://doi.org/10.1038/s41598-021-99581-6
|
[43]
|
Vincent, J.L., Quintairos e Silva, A., Couto Jr, L. and Taccone, F.S. (2016) The Value of Blood Lactate Kinetics in Critically Ill Patients: A Systematic Review. Critical Care, 20, Article No. 257. https://doi.org/10.1186/s13054-016-1403-5
|
[44]
|
Jansen, T.C., van Bommel, J., Schoonderbeek, F.J., Sleeswijk Visser, S.J., van der Klooster, J.M., Lima, A.P., Willemsen, S.P., Bakker, J. and LACTATE Study Group (2010) Early Lactate-Guided Therapy in Intensive Care Unit Patients: A Multicenter, Open-Label, Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine, 182, 752-761. https://doi.org/10.1164/rccm.200912-1918OC
|
[45]
|
Gauer, R., Forbes, D. and Boyer, N. (2020) Sepsis: Diagnosis and Management. American Family Physician, 101, 409-418.
|
[46]
|
Ryoo, S.M., Lee, J., Lee, Y.S., et al. (2018) Lactate Level versus Lactate Clearance for Predicting Mortality in Patients with Septic Shock Defined by Sepsis-3. Critical Care Medicine, 46, e489-e495. https://doi.org/10.1097/CCM.0000000000003030
|
[47]
|
Kern, W.V. and Rieg, S. (2020) Burden of Bacterial Bloodstream Infection—A Brief Update on Epidemiology and Significance of Multidrug-Resistant Pathogens. Clinical Microbiology and Infection, 26, 151-157. https://doi.org/10.1016/j.cmi.2019.10.031
|
[48]
|
Coburn, B., Morris, A.M., Tomlinson, G. and Detsky, A.S. (2012) Does This Adult Patient with Suspected Bacteremia Require Blood Cultures? Journal of the American Medical Association, 308, 502-511. https://doi.org/10.1001/jama.2012.8262
|
[49]
|
Long, B. and Koyfman, A. (2016) Best Clinical Practice: Blood Culture Utility in the Emergency Department. Journal of Emergency Medicine, 51, 529-539. https://doi.org/10.1016/j.jemermed.2016.07.003
|
[50]
|
Stalnikowicz, R. and Block, C. (2001) The Yield of Blood Cultures in a Department of Emergency Medicine. European Journal of Emergency Medicine, 8, 93-97. https://doi.org/10.1097/00063110-200106000-00004
|
[51]
|
Alam, N., Oskam, E., Strassen, P.M., Exter, P.V., van de Ven, P.M., Haak, H.R., et al. (2018) Prehospital Antibiotics in the Ambulance for Sepsis: A Multicenter, Open Label, Randomized Trial. The Lancet Respiratory Medicine, 6, 40-50. https://doi.org/10.1016/S2213-2600(17)30469-1
|
[52]
|
Shapiro, N.I., Wolfe, R.E., Wright, S.B., Moore, R. and Bates, D.W. (2008) Who Needs a Blood Culture? A Prospectively Derived and Validated Prediction Rule. Journal of Emergency Medicine, 35, 255-264. https://doi.org/10.1016/j.jemermed.2008.04.001
|
[53]
|
Delano, M.J. and Ward, P.A. (2016) The Immune System’s Role in Sepsis Progression, Resolution, and Long-Term Outcome. Immunological Reviews, 274, 330-353. https://doi.org/10.1111/imr.12499
|
[54]
|
Ljungström, L., Pernestig, A.K., Jacobsson, G., Andersson, R., Usener, B. and Tilevik, D. (2017) Diagnostic Accuracy of Procalcitonin, Neutrophil-Lymphocyte Count Ratio, C-Reactive Protein, and Lactate in Patients with Suspected Bacterial Sepsis. PLOS ONE, 12, e0181704. https://doi.org/10.1371/journal.pone.0181704
|
[55]
|
Martin, G.S. (2012) Sepsis, Severe Sepsis and Septic Shock: Changes in Incidence, Pathogen and Outcomes. Expert Review of Anti-infective Therapy, 10, 701-706. https://doi.org/10.1586/eri.12.50
|
[56]
|
Brown, L. and Yipp, B.G. (2022) Inflammatory Platelet Death Drives Sepsis. Nature Cardiovascular Research, 1, 689-690. https://doi.org/10.1038/s44161-022-00111-y
|
[57]
|
Guo, Y., Patil, N.K., Luan, L., Bohannon, J.K. and Sherwood, E.R. (2018) The Biology of Natural Killer Cells during Sepsis. Immunology, 153, 190-202. https://doi.org/10.1111/imm.12854
|
[58]
|
Chen, J. and Wei, H. (2021) Immune Intervention in Sepsis. Frontiers in Pharmacology, 12, Article 718089. https://doi.org/10.3389/fphar.2021.718089
|
[59]
|
Denk, S., Taylor, R.P., Wiegner, R., Cook, E.M., Lindorfer, M.A., Pfeiffer, K., et al. (2017) Complement C5a-Induced Changes in Neutrophil Morphology during Inflammation. Scandinavian Journal of Immunology, 86, 143-155. https://doi.org/10.1111/sji.12580
|
[60]
|
Sommerfeld, O., Medyukhina, A., Neugebauer, S., Ghait, M., Ulferts, S., Lupp, A., et al. (2020) Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis. Molecular Therapy, 29, 338-346. https://doi.org/10.1016/j.ymthe.2020.09.008
|
[61]
|
Vlaar, A.P.J., de Bruin, S., Busch, M., Timmermans, S., van Zeggeren, I.E., Koning, R., et al. (2020) Anti-C5a Antibody IFX-1 (Vilobelimab) Treatment versus Best Supportive Care for Patients with Severe COVID-19 (PANAMO): An Exploratory, Open-Label, Phase 2 Randomized Controlled Trial. The Lancet Rheumatology, 2, e764-e773. https://doi.org/10.1016/S2665-9913(20)30341-6
|
[62]
|
Rittirsch, D., Flierl, M.A. and Ward, P.A. (2008) Harmful Molecular Mechanisms in Sepsis. Nature Reviews Immunology, 8, 776-787. https://doi.org/10.1038/nri2402
|
[63]
|
Singer, M. (2007) Dysfunction of the Bioenergetic Pathway. In: Abraham, E. and Singer, M., Eds., Mechanisms of Sepsis-Induced Organ Dysfunction and Recovery, Springer, Berlin, 299-310. https://doi.org/10.1007/3-540-30328-6_21
|
[64]
|
Kübler, A. (2017) Sepsa—nowa uzgodniona definicja 2016. Chirurgia, 3, 19-21.
|
[65]
|
Sakr, Y., Lobo, S.M., Moreno, R.P., Gerlach, H., Ranieri, V.M., Michalopoulos, A., et al. (2012) Patterns and Early Evolution of Organ Failure in the Intensive Care Unit and Their Relation to Outcome. Critical Care, 16, Article No. R222. https://doi.org/10.1186/cc11868
|
[66]
|
Anderson, U. and Tracey, K.J. (2011) Reflex Principles of Immunological Homeostasis. Annual Review of Immunology, 30, 313-335. https://doi.org/10.1146/annurev-immunol-020711-075015
|
[67]
|
Friesecke, S., Stecher, S.S., Gross, S., Felix, S.B. and Nierhaus, A. (2017) Extracorporeal Cytokine Elimination as Rescue Therapy in Refractory Septic Shock a Prospective Single-Center Study. Journal of Artificial Organs, 20, 252-259. https://doi.org/10.1007/s10047-017-0967-4
|
[68]
|
Friesecke, S., Trager, K., Schittek, G.A., Molnar, Z., Bach, F., Kogelmann, K., et al. (2017) International Registry on the Use of the CytoSorb® Adsorber in ICU Patients: Study Protocol and Preliminary Results. Medizinische Klinik—Intensivmedizin und Notfallmedizin, 114, 699-707. https://doi.org/10.1007/s00063-017-0342-5
|
[69]
|
Hack, C.E. and Zeerleder, S. (2001) The Endothelium in Sepsis: Source of and a Target for Inflammation. Critical Care Medicine, 29, S21-S27. https://doi.org/10.1097/00003246-200107001-00011
|
[70]
|
Henneke, P. and Golenbock, D.T. (2002) Innate Immune Recognition of Lipopolysaccharide by Endothelial Cells. Critical Care Medicine, 30, S207-S213. https://doi.org/10.1097/00003246-200205001-00006
|
[71]
|
Chappell, D., Westphal, M. and Jacob, M. (2009) The Impact of the Glycocalyx on Microcirculatory Oxygen Distribution in Critical Illness. Current Opinion in Anaesthesiology, 22, 155-162. https://doi.org/10.1097/ACO.0b013e328328d1b6
|
[72]
|
Dolmatova, E.V., Wang, K.K., Mandavilli, R. and Griendling, K.K. (2021) The Effects of Sepsis on Endothelium and Clinical Implications. Cardiovascular Research, 117, 60-73. https://doi.org/10.1093/cvr/cvaa070
|
[73]
|
Dolmatova, E.V., Wang, K., Mandavilli, R. and Griendling, K.K. (2021) The Effects of Sepsis on Endothelium and Clinical Implications. Cardiovascular Research, 117, 60-73. https://doi.org/10.1093/cvr/cvaa070
|
[74]
|
Lentsck, M.H., et al. (2022) Prevalence and Factors Associated with Chronic Critical Disease in Hospitalized for Trauma in Intensive Care Units. https://doi.org/10.1590/1980-265x-tce-2022-0246pt
|
[75]
|
Asim, M., Amin, F. and El-Meneyar, A. (2020) Multiple Organ Dysfunction Syndrome: Contemporary Insights on the Clinicopathological Spectrum. Qatar Medical Journal, 2020, Article 22. https://doi.org/10.5339/qmj.2020.22
|
[76]
|
Sertaridou, E., Papaioannou, V., Kolios, G. and Pneumatikos, I. (2015) Gut Failure in Critical Care: Old School versus New School. Annals of Gastroenterology, 28, 309-322.
|
[77]
|
Levick, J.R. and Michel, C.C. (2010) Microvascular Fluid Exchange and the Revised Starling Principle. Cardiovascular Research, 87, 198-210. https://doi.org/10.1093/cvr/cvq062
|
[78]
|
Wu, C., Li, H., Zhang, P., Tian, C., Luo, J., Zhang, W., Bhandari, S., Jin, S. and Hao, Y. (2020) Lymphatic Flow: A Potential Target in Sepsis-Associated Acute Lung Injury. Journal of Inflammation Research, 13, 961-968. https://doi.org/10.2147/JIR.S284090
|
[79]
|
Singh, S. and Evans, T.W. (2006) Organ Dysfunction during Sepsis. Intensive Care Medicine, 32, 349-360. https://doi.org/10.1007/s00134-005-0038-9
|
[80]
|
Sonneville, R., de Montmollin, E., Poujade, J., Garrouste-Orgeas, M., Souweine, B., Darmon, M., et al. (2017) Potentially Modifiable Factors Contributing to Sepsis-Associated Encephalopathy. Intensive Care Medicine, 43, 1075-1084. https://doi.org/10.1007/s00134-017-4807-z
|
[81]
|
Fritze, T., Doblhammer, G., Widmann, C.N. and Heneka, M.T. (2020) Time Course of Dementia following Sepsis in German Health Claims Data. Neurology Neuroimmunology & Neuroinflammation, 8, e911. https://doi.org/10.1212/NXI.0000000000000911
|
[82]
|
Gao, Q. and Hernandes, M.S. (2021) Sepsis-Associated Encephalopathy and Blood-Brain Barrier Dysfunction. Inflammation, 44, 2143-2150. https://doi.org/10.1007/s10753-021-01501-3
|
[83]
|
Gu, M., Mei, X.L. and Zhao, Y.N. (2021) Sepsis and Cerebral Dysfunction: BBB Damage, Neuroinflammation, Oxidative Stress, Apoptosis and Autophagy as Key Mediators and the Potential Therapeutic Approaches. Neurotoxicity Research, 39, 489-503. https://doi.org/10.1007/s12640-020-00270-5
|
[84]
|
Reinhart, K., Bayer, O., Brunkhorst, F. and Meisner, M. (2002) Markers of Endothelial Damage in Organ Dysfunction and Sepsis. Critical Care Medicine, 30, S302-S312. https://doi.org/10.1097/00003246-200205001-00021
|
[85]
|
Gasparotto, J., Girardi, C.S., Somensi, N., Ribeiro, C.T., Moreira, J.C.F., Michels, M., Sonai, B., Rocha, M., Steckert, A.V., Barichello, T., et al. (2018) Receptor for Advanced Glycation End Products Mediates Sepsis-Triggered Amyloid-β Accumulation, Tau Phosphorylation, and Cognitive Impairment. Journal of Biological Chemistry, 293, 226-244. https://doi.org/10.1074/jbc.M117.786756
|
[86]
|
Sharshar, T., Annane, D., de la Grandmaison, G.L., Brouland, J.P., Hopkinson, N.S. and Françoise, G. (2004) The Neuropathology of Septic Shock. Brain Pathology, 14, 21-33. https://doi.org/10.1111/j.1750-3639.2004.tb00494.x
|
[87]
|
Nwafor, D.C., Brichacek, A.L., Mohammad, A.S., Griffith, J., Lucke-Wold, B.P., Benkovic, S.A., Geldenhuys, W.J., Lockman, P.R. and Brown, C.M. (2019) Targeting the Blood-Brain Barrier to Prevent Sepsis-Associated Cognitive Impairment. Journal of Central Nervous System Disease, 11, 1-14. https://doi.org/10.1177/1179573519840652
|
[88]
|
Dunn, A.J., Wang, J. and Ando, T. (1999) Effects of Cytokines on Cerebral Neurotransmission. In: Dantzer, R., Wollman, E.E. and Yirmiya, R., Eds., Cytokines, Stress, and Depression, Springer, New York, 117-127. https://doi.org/10.1007/978-0-585-37970-8_8
|
[89]
|
Dunn, A.J. (2000) Effects of the IL-1 Receptor Antagonist on the IL-1- and Endotoxin-Induced Activation of the HPA Axis and Cerebral Biogenic Amines in Mice. Neuroimmunomodulation, 7, 36-45. https://doi.org/10.1159/000026418
|
[90]
|
Russell, G. and Lightman, S. (2019) The Human Stress Response. Nature Reviews Endocrinology, 15, 525-534. https://doi.org/10.1038/s41574-019-0228-0
|
[91]
|
Russell, J.A. (2006) Management of Sepsis. The New England Journal of Medicine, 355, 1699-1713. https://doi.org/10.1056/NEJMra043632
|
[92]
|
Annane, D. (2010) Corticosteroids for Sepsis: Registry versus Cochrane Systematic Review. Critical Care, 14, Article No. 185. https://doi.org/10.1186/cc9188
|
[93]
|
Patel, G.P. and Balk, R.A. (2012) Systemic Steroids in Severe Sepsis and Septic Shock. American Journal of Respiratory and Critical Care Medicine, 185, 133-139. https://doi.org/10.1164/rccm.201011-1897CI
|
[94]
|
Barabutis, N., Khangoora, V., Marik, P.E. and Catravas, J.D. (2017) Hydrocortisone and Ascorbic Acid Synergistically Prevent and Repair Lipopolysaccharide-Induced Pulmonary Endothelial Barrier Dysfunction. Chest, 152, 954-962. https://doi.org/10.1016/j.chest.2017.07.014
|
[95]
|
Tavasoli, M., Azari, O., Kheirandish, R. and Abbasi, M.F. (2018) Evaluation of Combination Therapy with Hydrocortisone, Vitamin C, and Vitamin E in a Rat Model of Intestine Ischemia-Reperfusion Injury. Comparative Clinical Pathology, 27, 443-439. https://doi.org/10.1007/s00580-017-2610-4
|
[96]
|
Vandewalle, J. and Libert, C. (2020) Glucocorticoids in Sepsis: To Be or Not to Be. Frontiers in Immunology, 11, Article 549750. https://doi.org/10.3389/fimmu.2020.01318
|
[97]
|
Marik, P.E., Khangoora, V., Rivera, R., Hooper, M.H. and Catravas, J. (2017) Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective before-after Study. Chest, 151, 1229-1238. https://doi.org/10.1016/j.chest.2016.11.036
|
[98]
|
Scheinhorn, D., Stearn Hassenpflug, M., Votto, J., et al. (2007) Ventilator-Dependent Survivors of Catastrophic Illness Transferred to 23 Long-Term Care Hospitals for Weaning from Prolonged Mechanical Ventilation. Chest, 131, 76-84. https://doi.org/10.1378/chest.06-1079
|
[99]
|
Zilberberg, M., Luippold, R., Sulsky, S. and Shorr, A. (2008) Prolonged Acute Mechanical Ventilation, Hospital Resource Utilization, and Mortality in the United States. Critical Care Medicine, 36, 724-730. https://doi.org/10.1097/CCM.0B013E31816536F7
|
[100]
|
Chelluri, L., Im, K., Belle, S., et al. (2004) Long-Term Mortality, and Quality of Life after Prolonged Mechanical Ventilation. Critical Care Medicine, 32, 61-69. https://doi.org/10.1097/01.CCM.0000098029.65347.F9
|
[101]
|
Douglas, S., Daly, B., Brennan, P., Harris, S., Mochomovitz, M. and Dyer, M.A. (1997) Outcomes of Long-Term Ventilator Patients: A Descriptive Study. American Journal of Critical Care, 6, 99-105. https://doi.org/10.4037/ajcc1997.6.2.99
|
[102]
|
Van den Berghe, G. (2002) Neuroendocrine Pathobiology of Chronic Critical Illness. Critical Care Clinics, 18, 509-528.
|
[103]
|
Stanski, N.L. and Wong, H.R. (2020) Prognostic and Predictive Enrichment in Sepsis. Nature Reviews Nephrology, 16, 20-31. https://doi.org/10.1038/s41581-019-0199-3
|
[104]
|
Baghela, A., Pena, O.M., Lee, A.H., et al. (2021) Predicting Sepsis Severity at First Clinical Presentation: The Role of Endotypes and Mechanistic Signatures. eBioMedicine, 75, Article ID: 103776. https://doi.org/10.1016/j.ebiom.2021.103776
|
[105]
|
Llewelyn, M.J. and Cohen, J. (2007) Tracking the Microbes in Sepsis: Advancements in Treatment Bring Challenges for Microbial Epidemiology. Clinical Infectious Diseases, 44, 1343-1348. https://doi.org/10.1086/515403
|
[106]
|
Lazo-Vasquez, A., Piazza, M., Cordova, L., Bjork, L., Pharm, D., Zamora Gonzalez, R.A., Lichtenberger, P., Lichtenberger, P. and Baracco, G. (2021) 110. MRSA Nasal Swab as a Stewardship Tool to Guide IV Vancomycin in Diabetic Foot Infections. Open Forum Infectious Diseases, 8, S169-S170. https://doi.org/10.1093/ofid/ofab466.312
|
[107]
|
Davis, K., Stewart, J.J., Crouch, H.K., Florez, C.E. and Hospenthal, D.R. (2004) Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Colonization at Hospital Admission and Its Effect on Subsequent MRSA Infection. Clinical Infectious Diseases, 39, 776-782. https://doi.org/10.1086/422997
|
[108]
|
Chaudhry, A., Allen, B., Paylor, M. and Hayes, S. (2020) Evaluation of the Reliability of MRSA Screens in Patients Undergoing Universal Decolonization. American Journal of Health-System Pharmacy, 77, 1965-1972. https://doi.org/10.1093/ajhp/zxaa284
|
[109]
|
Hennessy, S.A., Shah, P.M., Guidry, C.A., Davies, S.W., Hranjec, T. and Sawyer, R.G. (2015) Can Nasal Methicillin-Resistant Staphylococcus aureus Screening Be Used to Avoid Empiric Vancomycin Use in Intra-Abdominal Infection? Surgical Infections, 16, 396-400. https://doi.org/10.1089/sur.2014.211
|
[110]
|
Rioux, J., Edwards, J., Bresee, L., Abu-Ulba, A., Yu, S., Dersch-Mills, D. and Wilson, B. (2017) Nasal-Swab Results for Methicillin-Resistant Staphylococcus aureus and Associated Infections. Canadian Journal of Hospital Pharmacy, 70, 107-112. https://doi.org/10.4212/cjhp.v70i2.1642
|
[111]
|
Seymour, C.W., Gesten, F., Prescott, H.C., Friedrich, M.E., Iwashyna, T.J., Phillips, G.S., Lemeshow, S., Osborn, T., Terry, K.M. and Levy, M.M. (2017) Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. The New England Journal of Medicine, 376, 2235-2244. https://doi.org/10.1056/NEJMoa1703058
|
[112]
|
Sterling, S.A., Miller, W.R., Pryor, J., Puskarich, M.A. and Jones, A.E. (2015) The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. Critical Care Medicine, 43, 1907-1915. https://doi.org/10.1097/CCM.0000000000001142
|
[113]
|
Paul, M., Shani, V., Muchtar, E., et al. (2010) Systematic Review, and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis. Antimicrobial Agents and Chemotherapy, 54, 4851-4863. https://doi.org/10.1128/AAC.00627-10
|
[114]
|
Kumar, A., Ellis, P., Arabi, Y., et al. (2009) Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock. Chest, 136, 1237-1248. https://doi.org/10.1378/chest.09-0087
|
[115]
|
Zilahi, G., McMahon, M.A., Povoa, P. and Martin-Loeches, I. (2016) Duration of Antibiotic Therapy in the Intensive Care Unit. Journal of Thoracic Disease, 8, 3774-3780. https://doi.org/10.21037/jtd.2016.12.89
|
[116]
|
Cag, Y., Caskurlu, H., Fan, Y., Cao, B. and Vahaboglu, H. (2016) Resistance Mechanisms. Annals of Translational Medicine, 4, Article 326. https://doi.org/10.21037/atm.2016.09.14
|
[117]
|
Bode, C., et al. (2014) Antibiotics Regulate the Immune Response in Both Presence and Absence of Lipopolysaccharide through Modulation of Toll-Like Receptors, Cytokine Production and Phagocytosis in vitro. International Immunopharmacology, 18, 27-34. https://doi.org/10.1016/j.intimp.2013.10.025
|
[118]
|
Blaser, M.J. (2016) Antibiotic Use and Its Consequences for the Normal Microbiome. Science, 352, 544-545. https://doi.org/10.1126/science
|
[119]
|
Halbach, J.L., Wang, A.W., Hawisher, D., Cauvi, D.M., Lizardo, R.E., Rosas, J., Reyes, T., Escobedo, O., Bickler, S.W., Coimbra, R. and De Maio, A. (2017) Why Antibiotic Treatment Is Not Enough for Sepsis Resolution: an Evaluation in an Experimental Animal Model. Infection and Immunity, 85, e00664-17. https://doi.org/10.1128/IAI.00664-17
|
[120]
|
Roberts, S.C. and Zembower, T.R. (2021) Global Increases in Antibiotic Consumption: A Concerning Trend for WHO Targets. The Lancet Infectious Diseases, 21, 10-11. https://doi.org/10.1016/S1473-3099(20)30456-4
|
[121]
|
Im, Y., Kang, D., Ko, R.E., et al. (2022) Time-to-Antibiotics and Clinical Outcomes in Patients with Sepsis and Septic Shock: A Prospective Nationwide Multicenter Cohort Study. Critical Care, 26, Article 19. https://doi.org/10.21203/rs.3.rs-1071881/v1
|
[122]
|
Shi, R., Hamzaoui, O., De Vita, N., Monnet, X. and Teboul, J.L. (2020) Vasopressors in Septic Shock: Which, When, and How Much? Annals of Translational Medicine, 8, Article 794. https://doi.org/10.21037/atm.2020.04.24
|